VALIDATION FROM INVESTORS AND BIG PHARMA AT AN EARLY STAGE OF CORPORATE DEVELOPMENT
Confo Therapeutics is a private company founded in 2015 by VIB, VUB (Jan Steyaert lab) and Capricorn Partners, with the support of MINTS, PMV, QBIC and V-Bio Ventures.
As an early-stage company moving towards clinical development, we have established a strong financial position backed by an impressive consortium of global investors including: BGV, Capricorn Partners, Fund+, Perceptive Advisors, PMV, University of Michigan, Qbic, V-Bio, VIB and Wellington Partners.
Our deals with big pharma further validate the novelty and potential of our GPCR drug discovery engine.
VIB is an entrepreneurial non-profit research institute, with a clear focus on groundbreaking strategic basic research in life sciences and operates in close partnership with the five universities in Flanders – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel and Hasselt University.
Vrije Universiteit Brussel is an internationally oriented university in Brussels, the heart of Europe. Through tailor-made high quality research and education, VUB wants to contribute in an active and committed way to a better society for tomorrow.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.